{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:38:38Z","timestamp":1794335918215,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,28]],"date-time":"2027-02-28T00:00:00Z","timestamp":1803772800000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nuclcard.2025.102451","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T15:07:46Z","timestamp":1757084866000},"page":"102451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A tale of two tracers - amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05)"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4993-5782","authenticated-orcid":false,"given":"Emily B.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kassira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4685-8128","authenticated-orcid":false,"given":"Alan","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-4586","authenticated-orcid":false,"given":"Spencer","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5516-8578","authenticated-orcid":false,"given":"Jonathan S.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2025.102451_bib1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaccao.2021.07.010","article-title":"Electrophysiological manifestations of cardiac amyloidosis: JACC: CardioOncology state-of-the-Art review","volume":"3","author":"Hartnett","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.nuclcard.2025.102451_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","article-title":"Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomeclature Committee","volume":"31","author":"Buxbaum","year":"2024","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2025.102451_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.nuclcard.2025.102451_bib5","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2025.102451_bib6","first-page":"609","article-title":"Treatment of amyloid light chain cardiac amyloidosis: systematic review and future directions","volume":"20","author":"Alsomali","year":"2022","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.nuclcard.2025.102451_bib8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.nuclcard.2025.102451_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HPC.0000000000000183","article-title":"Transthyretin cardiac amyloidosis as diagnosed by 99mTc-PYP scanning in patients with acute heart failure and preserved ejection fraction","volume":"18","author":"Lo","year":"2019","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01254559","article-title":"Imaging amyloidosis with radiolabelled SAP","volume":"22","author":"Hawkins","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102451_bib12","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC review topic of the week","volume":"75","author":"Hanna","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102451_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","article-title":"Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis","volume":"26","author":"Cappelli","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib15","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2025.102451_bib16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using (124)I-evuzamitide ((124)I-P5+14) versus (18)F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102451_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ehjci\/jeae332","article-title":"Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis","volume":"26","author":"Vergaro","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102451_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11886-024-02114-6","article-title":"Recent advances in positron emission tomography radiotracers to image cardiac amyloidosis","volume":"26","author":"Romero","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.nuclcard.2025.102451_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.hfc.2025.01.009","article-title":"Current status of radionuclide imaging of transthyretin cardiac amyloidosis","volume":"21","author":"Waheed","year":"2025","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.nuclcard.2025.102451_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13506129.2017.1295372","article-title":"A bifunctional peptide, \"peptope\", for pre-targeting antibody 7D8 to systemic amyloid deposits","volume":"24","author":"Wall","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2025.102451_bib21","doi-asserted-by":"crossref","first-page":"E10839","DOI":"10.1073\/pnas.1805515115","article-title":"Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy","volume":"115","author":"Wall","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nuclcard.2025.102451_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1275372","article-title":"Development and characterization of a prototypic pan-amyloid clearing agent - a novel murine peptide-immunoglobulin fusion","volume":"14","author":"Foster","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib23","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3389\/fimmu.2017.01082","article-title":"A peptide-Fc Opsonin with pan-amyloid reactivity","volume":"8","author":"Foster","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301756","article-title":"Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis","volume":"19","author":"Kennel","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.nuclcard.2025.102451_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.peptides.2014.07.024","article-title":"Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation","volume":"60","author":"Martin","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.nuclcard.2025.102451_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep22695","article-title":"Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis","volume":"6","author":"Martin","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nuclcard.2025.102451_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1536012117708705","article-title":"Dual-energy SPECT and the development of peptide p5+14 for imaging amyloidosis","volume":"16","author":"Wall","year":"2017","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nuclcard.2025.102451_bib28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine ((124)I) evuzamitide ((124)I-p5+14): a Phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102451_bib29","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1073\/pnas.1103247108","article-title":"In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides","volume":"108","author":"Wall","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nuclcard.2025.102451_bib30","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.3390\/molecules20057657","article-title":"Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis","volume":"20","author":"Wall","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.nuclcard.2025.102451_bib31","doi-asserted-by":"crossref","first-page":"26091","DOI":"10.1074\/jbc.272.42.26091","article-title":"Amyloid-specific heparan sulfate from human liver and spleen","volume":"272","author":"Lindahl","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nuclcard.2025.102451_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/joim.12061","article-title":"Pathophysiology of heparan sulphate: many diseases, few drugs","volume":"273","author":"Lindahl","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.nuclcard.2025.102451_bib33","first-page":"447","volume":"35","year":"2021","journal-title":"WHO Drug Inf"},{"key":"10.1016\/j.nuclcard.2025.102451_bib34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.apradiso.2014.03.026","article-title":"Production of iodine-124 and its applications in nuclear medicine","volume":"90","author":"Braghirolli","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nuclcard.2025.102451_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/672094","article-title":"124 Iodine: a longer-life positron emitter isotope-new opportunities in molecular imaging","volume":"2014","author":"Cascini","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.nuclcard.2025.102451_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jlcr.3891","article-title":"Use of radioiodine in nuclear medicine-A brief overview","volume":"64","author":"Ferris","year":"2021","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nuclcard.2025.102451_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12149-017-1198-8","article-title":"Topics of nuclear medicine research in Europe","volume":"31","author":"Inubushi","year":"2017","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102451_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/jlcr.3883","article-title":"Study of the (99m) Tc-labeling conditions of 6-hydrazinonicotinamide-conjugated peptides from a new perspective: introduction to the term radio-stoichiometry","volume":"63","author":"Kaihani","year":"2020","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nuclcard.2025.102451_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1021\/bc060291m","article-title":"In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules","volume":"18","author":"Tran","year":"2007","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nuclcard.2025.102451_bib40","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3803\/EnM.2021.1198","article-title":"Deiodinases and the three types of thyroid hormone deiodination reactions","volume":"36","author":"Sabatino","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.nuclcard.2025.102451_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/JOE-10-0481","article-title":"Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease","volume":"209","author":"Maia","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153635","article-title":"Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution","volume":"227","author":"Tateishi","year":"2021","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.nuclcard.2025.102451_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17996\/anc.24-00001","article-title":"A quantitative diagnostic method using (99m)Tc-pyrophosphate lateral planar images to distinguish between transthyretin amyloid cardiomyopathy and false-positive images due to blood pools","volume":"10","author":"Hara","year":"2024","journal-title":"Ann Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102146","article-title":"Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [(123)I]-MIBG SPECT\/CT: the I-NERVE study","volume":"45","author":"Tubben","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102451_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2025.01.018","article-title":"Early detection of transthyretin cardiac amyloidosis using (124)I-evuzamitide positron emission tomography\/computed tomography","author":"Smiley","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102451_bib46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0735-1097(25)01667-5","article-title":"Diagnostic performance of cardiac and whole-body 124I-evuzamitide (AT-01) PET\/MRI in systemic amyloidosis","volume":"85","author":"Masri","year":"2025","journal-title":"JACC (J Am Coll Cardiol)"},{"key":"10.1016\/j.nuclcard.2025.102451_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040629","article-title":"Clinical confirmation of pan-amyloid reactivity of radioiodinated peptide (124)I-p5+14 (AT-01) in patients with diverse types of systemic amyloidosis demonstrated by PET\/CT imaging","volume":"16","author":"Martin","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nuclcard.2025.102451_bib48","first-page":"1","article-title":"Longitudinal PET\/CT imaging with iodine ((124)I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis","author":"Lands","year":"2023","journal-title":"Amyloid"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125003253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125003253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:51:50Z","timestamp":1773186710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358125003253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"alternative-id":["S1071358125003253"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102451","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A tale of two tracers - amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05)","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Nuclear Cardiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102451"}}